Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04VSM
|
|||
| Former ID |
DCL000297
|
|||
| Drug Name |
CS-8958
|
|||
| Synonyms |
Inavir; Laninamivir octanoate; R-118958
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 3 | [1] | |
| Company |
Biota
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H36N4O8
|
|||
| Canonical SMILES |
CCCCCCCC(=O)OCC(C(C1C(C(C=C(O1)C(=O)O)N=C(N)N)NC(=O)C)OC)O
|
|||
| InChI |
1S/C21H36N4O8/c1-4-5-6-7-8-9-16(28)32-11-14(27)18(31-3)19-17(24-12(2)26)13(25-21(22)23)10-15(33-19)20(29)30/h10,13-14,17-19,27H,4-9,11H2,1-3H3,(H,24,26)(H,29,30)(H4,22,23,25)/t13-,14+,17+,18+,19+/m0/s1
|
|||
| InChIKey |
UKTIJASCFRNWCB-RMIBSVFLSA-N
|
|||
| CAS Number |
CAS 203120-46-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:134741
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Influenza Neuraminidase (Influ NA) | Target Info | Inhibitor | [2] |
| KEGG Pathway | Other glycan degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00803595) A Multinational Phase III Study of CS-8958 (MARVEL). U.S. National Institutes of Health. | |||
| REF 2 | Developing new antiviral agents for influenza treatment: what does the future hold Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.